Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with a distinguished global Contract Research Organ ...